
Iopamidol Injectable Solution
Form: Injectable Solution
Strength: 37%, 61%, 76%, and 78%
Reference Brands: Isovue(US), Iopamiro(EU)
Category: Contrast Agent
Iopamidol injectable solution, marketed as Isovue in the US and Iopamiro in the EU, is approved for use as a contrast agent in X-ray and CT imaging. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability, facilitating high-quality diagnostic imaging in healthcare systems globally.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Sulfur Hexafluoride Microbubbles injection
Strength: 60.7mg
Form: injection
Reference Brands: SonoVue(EU)
View Details Get EnquiryBarium Sulfate Suspension
Strength: 30% w/v , 40% w/v
Form: Powder for oral suspension
Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)
View Details Get EnquiryGadoxetate Injectable Solution
Strength: 0.25 mmol/mL
Form: Injectable Solution
Reference Brands: Eovist(US)
View Details Get EnquiryGadofosveset Injectable solution
Strength: 0.03 mmol/kg
Form: Injectable Solution
Reference Brands: Ablivar(US & EU)
View Details Get Enquiry